1
by Németh, Bertalan, Csanádi, Marcell, Inotai, András, Ameyaw, David
Published 2022
World Health Organization
... on financing high-priced medicines. The market access strategies for innovative medicines in LICs usually...

2
by Docteur, Elizabeth
Published 2022
World Health Organization
...Concerns about affordable access to medicines reflect the emergence of new, high-priced medicines...

3
by Lemmens, Trudo, Ghimire, Kanksha Mahadevia, Perehudoff, Katrina, Persaud, Navindra
Published 2022
World Health Organization
...High prices can significantly restrict access to medicines and may have an impact on health equity...

4
by Perehudoff, Katrina, Mara, Kaitlin, Hoen, Ellen F. M. 't
Published 2021
HEN, Health Evidence Network, WHO Regional Office for Europe
... of pharmaceutical markets in two main areas: (i) the price transparency of medicines, vaccines and health products...

5
by Panteli, Dimitra, Edwards, Suzanne
Published 2018
World Health Organization, Regional Office for Europe

6
by Cylus, Jonathan, Figueras, Josep, Normand, Charles E. M.
Published 2019
World Health Organization, Regional Office for Europe
... effect on health expenditure forecasts, compared to traditional cost drivers such as price growth...

7
by Cylus, Jonathan, Figueras, Josep, Normand, Charles E. M.
Published 2019
World Health Organization, Regional Office for Europe
... effect on health expenditure forecasts, compared to traditional cost drivers such as price growth...

8
by Ardal, Christine, Lopert, Ruth, Mestre-Ferrandiz, Jorge
Published 2022
World Health Organization
... to develop ways of achieving better, more affordable access to novel, high-priced medicines. To provide a...

9
by Moon, Suerie, Vieira, Marcela, Alonso Ruiz, Adrián, Navarro, Danielle
Published 2022
World Health Organization
...Public concern has been increasing about the high prices of novel medicines, limits on availability...